ArticleSignal transduction and targeted therapy2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming.
Laiyan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.